A recent study indicates that patients who discontinue popular slimming jabs like Wegovy and Mounjaro tend to recover reduced body mass at a significantly accelerated pace than those who end conventional lifestyle plans.
Research printed in a leading medical journal demonstrates that while obese people frequently drop substantial amounts of their total mass while on the medication, the mass returns at an estimated rate of 0.8 kg per month once they quit.
"Users using such drugs need to be cognizant of the risk of rapid weight regain when the medication concludes," stated researcher Dr. Susan Jebb.
That rate of recovery implies a reversion to starting weight within about one and a half years.
Weighing Approaches
The analysis, which looked at 37 of studies involving thousands of participants, compared the effects of the injectable medications with conventional dieting.
Scientists point out that individuals who shed pounds through diet and exercise typically experience a slower creep back—approximately 100 grams monthly—post-intervention.
The Reason for the Rapid Regain
Experts propose the mode of action of the jabs accounts for the heightened regain.
The injections imitate a body's own chemical called GLP-1, which controls feelings of fullness.
"Sustained high doses of GLP-1 levels far above than the body's typical production could lead to the system to generate a reduced amount of its endogenous hormone, and could lessen responsiveness to its actions," explained Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this hormone supplement results in hunger is unsuppressed, making binge eating a significant risk."
A Chronic Issue?
Medical guidelines advise the injections for people with weight-linked health risks, accompanied by recommended diet and exercise modifications.
A number of clinicians say that, given the likelihood of relapse, the therapy is often ongoing.
This view is reinforced by drug manufacturers, who state that the results "highlight the chronic character of excess weight," similar to managing diseases like diabetes.
User Testimonies
People who have come off the medication describe a powerful resurgence of cravings.
"It was like a trigger that goes on and you become starving," described an individual.
This difficulty is worsened if users have not adopted sustainable dietary or behavioural changes during therapy.
Widespread Adoption
Figures indicate that millions of adults in the UK have tried these injections in the last 12 months, with interest being substantial.
- Use is higher among females than males.
- The middle-aged demographic shows the highest usage rates.
- Many access the drugs through private prescriptions rather than public health services.
Ultimately, experts emphasize that while these medications are powerful tools for shedding pounds, they are not a standalone cure and lasting health benefits likely depends on integrated lifestyle management.
